COVAX
COVAX (COVID-19 Vaccines Global Access) er en international alliance dannet tidligt i coronaviruspandemien 2020 af Verdenssundhedsorganisationen (WHO) under Global Alliance for Vaccines and Immunization (GAVI).
I samarbejde med Coalition for Epidemic Preparedness Innovations (CEPI) vil alliancen etablere en hurtig og bred fordeling blandt fremtidige COVID-19-vacciner blandt alle lande med behov. CEPI understøtter en række vacciner, som alle i denne alliance kan modtage hvis vaccinerne lykkes. Alliancen sigter mod at mellem- og lavindkomstlande har god adgang til vacciner.[1]
Referencer
- ^ "COVAX explained" fra Gavi.org – Af Dr Seth Berkley, CEO of Gavi, the Vaccine Alliance, 3. september 2020 ("... COVAX is one of three pillars of the Access to COVID-19 Tools (ACT) Accelerator, which was launched in April by the World Health Organization (WHO), the European Commission and France in response to this pandemic. Bringing together governments, global health organisations, manufacturers, scientists, private sector, civil society and philanthropy, with the aim of providing innovative and equitable access to COVID-19 diagnostics, treatments and vaccines. The COVAX pillar is focussed on the latter. ...")
Eksterne henvisninger
- "172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility" fra Who.int, 24. august 2020
- "Danmark og EU er med i international vaccinealliance for at sikre COVID19-vacciner til lav- og mellemindkomstlande" fra Laegemiddelstyrelsen.dk, 22. september 2020 (Lægemiddelstyrelsen)
- "Access to COVID-19 Tools Accelerator" (enwiki)
- Om "CEPI" fra Cepi.net; Coalition for Epidemic Preparedness Innovations (en): "CEPI is an innovative global partnership between public, private, philanthropic, and civil society organisations launched in Davos in 2017 to develop vaccines to stop future epidemics. ..."
| |||||||||||||||||||||||||||||||||||||
 | Spire Denne artikel om lægevidenskab er en spire som bør udbygges. Du er velkommen til at hjælpe Wikipedia ved at udvide den. |
Medier brugt på denne side
SARS-CoV-2 without background.png
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19).
This illustration, created at the Centers for Disease Control and Prevention (CDC), reveals ultrastructural morphology exhibited by coronaviruses. Note the spikes that adorn the outer surface of the virus, which impart the look of a corona surrounding the virion, when viewed electron microscopically. A novel coronavirus, named Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2), was identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China in 2019. The illness caused by this virus has been named coronavirus disease 2019 (COVID-19).
Nuvola Red Plus.svg
Forfatter/Opretter: Anomie, Licens: LGPL
Red plus symbol in a circle, based on Image:Nuvola apps kcmdrkonqi.png
Forfatter/Opretter: Anomie, Licens: LGPL
Red plus symbol in a circle, based on Image:Nuvola apps kcmdrkonqi.png
